Company Overview
Snapshot
Founded in February 2003 by Ben Beiski and Andy Wolff, Saliwell operates with 1–10 employees. The company has raised $2.18 million across one funding round and is known for its SaliPen device, which stimulates natural saliva production to treat dry mouth disease.
Business overview
Saliwell is a Health Tech & Life Sciences company focused on developing medical devices for treating xerostomia, commonly known as dry mouth disease. Its core product, the SaliPen, utilizes electro-stimulation to increase natural saliva production. The device features a removable intraoral design with two flexible arms and stimulating electrodes placed under the tongue, providing a practical and effective solution for patients suffering from dry mouth. Saliwell operates in the Medical Devices sector, specifically within Medical Treatment & Therapeutics, targeting patients globally.
Strategic signal
In November 2018, Saliwell's SaliPen device was trialled at Great Western Hospital, indicating a significant step in clinical validation and market penetration for its electro-stimulation technology. This development signals to investors a progression towards broader adoption and regulatory acceptance within the medical device industry, highlighting the company's commitment to bringing its innovative dry mouth treatment to patients through established healthcare channels.
Log in to access full profile ›Company Intelligence Q&A
- What is Saliwell's primary product?
- Saliwell's primary product is the SaliPen, a device designed to stimulate natural saliva production for treating dry mouth disease (xerostomia) using electro-stimulation.
- When was Saliwell founded and by whom?
- Saliwell was founded in February 2003 by Ben Beiski and Andy Wolff.
- What was a key development for Saliwell in November 2018?
- In November 2018, Saliwell's SaliPen device was trialled at Great Western Hospital, as reported by www.swindonadvertiser.co.uk.
- What was a significant corporate event for Saliwell in January 2011?
- In January 2011, Atia Group shareholders approved a merger with Saliwell, according to www.globes.co.il.
- Has Saliwell received any non-equity funding?
- In September 2006, Saliwell received a grant from the European Innovation Council.